KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Change in Acquisitions & Divestments (2017 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Change in Acquisitions & Divestments for 11 consecutive years, with $123.9 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 25.19% to $123.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $574.5 million through Dec 2025, down 17.98% year-over-year, with the annual reading at $574.5 million for FY2025, 17.98% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $123.9 million at Xenon Pharmaceuticals, up from $113.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $235.7 million in Q2 2024, with the low at $20.3 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $118.4 million, with a median of $128.9 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 55.87% in 2022, then soared 674.7% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $42.3 million in 2021, then surged by 147.8% to $104.8 million in 2022, then skyrocketed by 30.66% to $136.9 million in 2023, then grew by 21.01% to $165.6 million in 2024, then decreased by 25.19% to $123.9 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $123.9 million, $113.5 million, and $171.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.